The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 18, 2007, Pages 7570-7575

  Welm, Alana L ^a,f   Sneddon, Julie B ^c   Taylor, Carmen ^b,d   Nuyten, Dimitry S A ^e   Van De Vijver, Marc J ^e   Hasegawa, Bruce H ^b,d   Bishop, J Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY   (United States)

^d University of California at Berkeley   (United States)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Bone metastasis; Inflammation; Prognostic factor; Ron; Tumor

Indexed keywords

MACROPHAGE STIMULATING 1 RECEPTOR; MACROPHAGE STIMULATING PROTEIN; MATRIPTASE; PLASMA PROTEIN; RON PROTEIN; UNCLASSIFIED DRUG; ONCOPROTEIN; PROTEIN TYROSINE KINASE; SCATTER FACTOR; SERINE PROTEINASE; ST14 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BREAST CANCER; GENE OVEREXPRESSION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; METASTASIS; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROGNOSIS; RETROVIRUS; TUMOR GROWTH; VIRUS INFECTION; ANIMAL; BONE TUMOR; BREAST TUMOR; CELL TRANSFORMATION; DISEASE MODEL; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MORTALITY; PATHOLOGY; RISK FACTOR; SIGNAL TRANSDUCTION; TIME;

ANIMALIA;

ANIMALS; BONE NEOPLASMS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MICE; NEOPLASM METASTASIS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RISK FACTORS; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 34250653300     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0702095104     Document Type: Article

References (39)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ (2004) CA Cancer J Clin 54:8-29.
2. Leonard EJ (1997) Ciba Found Symp 212:183-191; discussion 192-187.
3. Lutz MA, Correll PH (2003) J Leukocyte Biol 73:802-814.
4. Wang MH, Skeel A, Leonard EJ (1996) J Clin Invest 97:720-727.
5. Bhatt AS, Welm AL, Farady CJ, Vasquez M, Wilson K, Craik C (2007) Proc Natl Acad Sci USA 104:5771-5776.
6. Santoro MM, Gaudino G, Marchisio PC (2003) Dev Cell 5:257-271.
7. Wang MH, Montero-Julian FA, Dauny I, Leonard EJ (1996) Oncogene 13:2167-2175.
8. Wang D, Shen Q, Chen YQ, Wang MH (2004) Oncogene 23:1668-1680.
9. Peace BE, Hughes MJ, Degen SJ, Waltz SE (2001) Oncogene 20:6142-6151.
10. Wang MH, Wang D, Chen YQ (2003) Carcinogenesis 24:1291-1300.
11. Chen YQ, Zhou YQ, Fisher JH, Wang MH (2002) Oncogene 21:6382-6386.
12. Kang JY, Dolled-Filhart M, Ocal IT, Singh B, Lin CY, Dickson RB, Rimm DL, Camp RL (2003) Cancer Res 63:1101-1105.
13. Maggiora P, Marchio S, Stella MC, Giai M, Belfiore A, De Bortoli M, Di Renzo MF, Costantino A, Sismondi P, Comoglio PM (1998) Oncogene 16:2927-2933.
14. Lee WY, Chen HH, Chow NH, Su WC, Lin PW, Guo HR (2005) Clin Cancer Res 11:2222-2228.
15. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al. (2002) Nature 415:530-536.
16. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, et al. (2002) N Engl J Med 347:1999-2009.
17. Guy CT, Cardiff RD, Muller WJ (1992) Mol Cell Biol 12:954-961.
18. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, Pollard JW (2003) Am J Pathol 163:2113-2126.
19. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ (1994) Genes Dev 8:23-32.
20. Rauh MJ, Blackmore V, Andrechek ER, Tortorice CG, Daly R, Lai VK, Pawson T, Cardiff RD, Siegel PM, Muller WJ (1999) Mol Cell Biol 19:8169-8179.
21. Webster MA, Hutchinson JN, Rauh MJ, Muthuswamy SK, Anton M, Tortorice CG, Cardiff RD, Graham FL, Hassell JA, Muller WJ (1998) Mol Cell Biol 18:2344-2359.
22. Bieche I, Onody P, Tozlu S, Driouch K, Vidaud M, Lidereau R (2003) Int J Cancer 106:758-765.
23. Welm AL, Kim S, Welm BE, Bishop JM (2005) Proc Natl Acad Sci USA 102:4324-4329.
24. Degen SJ, McDowell SA, Waltz SE, Gould F, Stuart LA, Carritt B (1998) DNA Seq 8:409-413.
25. Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sorlie T, Dai H, He YD, van't Veer LJ, Bartelink H, et al. (2005) Proc Natl Acad Sci USA 102:3738-3743.
26. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2001) Proc Natl Acad Sci USA 98:10869-10874.
27. Cox D (1972) J R Stat Soc B 34:187-220.
28. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, et al. (2006) BMC Genomics 7:96.
29. Perreard L, Fan C, Quackenbush JF, Mullins M, Gauthier NP, Nelson E, Mone M, Hansen H, Buys SS, Rasmussen K, et al. (2006) Breast Cancer Res 8:R23.
30. Peace BE, Toney-Earley K, Collins MH, Waltz SE (2005) Cancer Res 65:1285-1293.
31. Lin EY, Pollard JW (2004) Novartis Found Symp 256:158-168; discussion 168-172:259-269.
32. Lin EY, Pollard JW (2004) Br J Cancer 90:2053-2058.
33. Lin EY, Nguyen AV, Russell RG, Pollard JW (2001) J Exp Med 193:727-740.
34. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD (1990) Nature 345:442-444.
35. Ortega N, Behonick DJ, Colnot C, Cooper DN, Werb Z (2005) Mol Biol Cell 16:3028-3039.
36. Kurihara N, Iwama A, Tatsumi J, Ikeda K, Suda T (1996) Blood 87:3704-3710.
37. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, van de Rijn M, Botstein D, Brown PO (2004) PLoS Biol 2:E7.
38. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, et al. (2003) Proc Natl Acad Sci USA 100:8418-8423.
39. Zinser GM, Leonis MA, Toney K, Pathrose P, Thobe M, Kader SA, Peace BE, Beauman SR, Colllins MH, Waltz SE (2006) Cancer Res 66:11967-11974.